Cooley advised Headline on the deal. Headline, a leading tech-enabled global venture capital firm, announced the closing of its North America-focused early-stage fund, Headline US VII, with...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the initial purchasers in the offering while Cooley advised Cytokinetics. Cytokinetics, Incorporated, a late-stage biopharmaceutical company, has announced the pricing of its...
You must be a Standard 1 Year member to access this content.
Skadden advised Vertex Pharmaceuticals Incorporated on the deal while Cooley represented ViaCyte. Vertex Pharmaceuticals Incorporated (“Vertex”) has entered into a definitive agreement under which Vertex will acquire...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Blueprint Medicines Corporation on the deal while Cooley represented Sixth Street. Blueprint Medicines Corporation (NASDAQ: BPMC) announced its strategic financing collaborations with Sixth...
You must be a Standard 1 Year member to access this content.
Harneys, working with CYL & Partners in association with Cooley HK and Commerce & Finance Law, acted as Cayman Islands counsel to TI Cloud Inc. Paul...
You must be a Standard 1 Year member to access this content.
CYL & Partners in association with Cooley Hong Kong and Maples represented GOGOX. Paul Hastings advised the joint sponsors and underwriters. GOGOX HOLDINGS LIMITED announced the HK$670...
You must be a Standard 1 Year member to access this content.
Cooley advised Obvious Ventures on the deal. Obvious Ventures, a venture capital firm investing in early-stage, purpose-driven entrepreneurs reimagining trillion-dollar industries, announced its raise of two new...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Biospring Partners on the deal. Biospring Partners, a growth equity firm exclusively focused on business-to-business (B2B) life sciences technology companies, announced the closing of...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Qiming Venture Partners USA on the deal. Qiming Venture Partners USA (Qiming US), a leading US healthcare investment firm, announced the closing of its...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Vendr on the deal. Vendr, a software as a service buying platform, announced its $150 million Series B funding round, bringing the company...
You must be a Standard 1 Year member to access this content.
Cooley advised Bonfire Ventures on the deal. Bonfire Ventures, a venture capital firm investing in seed-stage business-to-business (B2B) software companies, announced the closing of its third core...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Amplify Partners on the deal. Amplify Partners, an early-stage venture capital firm dedicated to technical founders, announced the formation of two new funds –...
You must be a Standard 1 Year member to access this content.
